In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography.

OBJECTIVE Cardiac tissue engineering has been proposed as a treatment to repair impaired hearts. Bioengineered cardiac grafts are created by combining autologous cell transplantation with a degradable scaffold as a temporary extracellular matrix. Here we present a system for engineered myocardium combining cultured cardiomyocytes and a novel biodegradable scaffold with a unique extracellular matrix-like topography. METHODS Cardiomyocytes were harvested from neonatal rats and cultured in vitro on biodegradable electrospun nanofibrous poly(epsilon-caprolactone) meshes. Between days 5 and 7, the meshes were overlaid to construct 3-dimensional cardiac grafts. On day 14 of in vitro culture, the engineered cardiac grafts were analyzed by means of histology, immunohistochemistry, and scanning electron microscopy. RESULTS The cultured cardiomyocytes attached well to the meshes, and strong beating was observed throughout the experimental period. The average fiber diameter of the scaffold is about 250 nm, well below the size of an individual cardiomyocyte. Hence the number of cell-cell contacts is maximized. Constructs with up to 5 layers could be formed without any incidence of core ischemia. The individual layers adhered intimately. Morphologic and electrical communication between the layers was established, as verified by means of histology and immunohistochemistry. Synchronized beating was also observed. CONCLUSIONS This report demonstrates the formation of thick cardiac grafts in vitro and the versatility of biodegradable electrospun meshes for cardiac tissue engineering. It is envisioned that cardiac grafts with clinically relevant dimensions can be created by using this approach and combining it with new technologies to induce vascularization.

[1]  R. Weisel,et al.  The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. , 2001, The Journal of thoracic and cardiovascular surgery.

[2]  R. Weisel,et al.  Optimal Biomaterial for Creation of Autologous Cardiac Grafts , 2002, Circulation.

[3]  Karthik Nagapudi,et al.  Engineered collagen–PEO nanofibers and fabrics , 2001, Journal of biomaterials science. Polymer edition.

[4]  Y. Ikada,et al.  First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo , 2003, Circulation.

[5]  Andreas Hess,et al.  Cardiac Grafting of Engineered Heart Tissue in Syngenic Rats , 2002, Circulation.

[6]  R. Benza,et al.  Current outcomes following heart transplantation. , 2004, Seminars in thoracic and cardiovascular surgery.

[7]  T. Okano,et al.  Cell sheet engineering for myocardial tissue reconstruction. , 2003, Biomaterials.

[8]  J. Vacanti,et al.  Endothelialized Networks with a Vascular Geometry in Microfabricated Poly(dimethyl siloxane) , 2004 .

[9]  S M Schwartz,et al.  Skeletal myoblast transplantation for repair of myocardial necrosis. , 1996, The Journal of clinical investigation.

[10]  Y. Imai,et al.  Transplantation of a tissue-engineered pulmonary artery. , 2001, The New England journal of medicine.

[11]  Mitsuo Umezu,et al.  Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.

[12]  J. Vacanti,et al.  Tissue engineering. , 1993, Science.

[13]  J. Leor,et al.  Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium? , 2000, Circulation.

[14]  T. Okano,et al.  Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. , 2001, Tissue engineering.

[15]  M. Papadaki Cardiac muscle tissue engineering. , 2003, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[16]  Jennifer L West,et al.  Tissue engineered small-diameter vascular grafts. , 2003, Clinics in plastic surgery.

[17]  G. Cossu,et al.  Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Thomas Eschenhagen,et al.  Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  R. Weisel,et al.  Survival and function of bioengineered cardiac grafts. , 1999, Circulation.

[20]  R J Cohen,et al.  Cardiac muscle tissue engineering : toward an in vitro model for electrophysiological studies , 1999 .

[21]  T. Shinoka Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold. , 2002, Artificial organs.

[22]  Narutoshi Hibino,et al.  Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. , 2003, The Journal of thoracic and cardiovascular surgery.

[23]  J. Vacanti,et al.  Contractile cardiac grafts using a novel nanofibrous mesh. , 2004, Biomaterials.

[24]  J. Vacanti,et al.  A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. , 2003, Biomaterials.

[25]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[26]  John Layman,et al.  Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[27]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.